| Celtic Hospice 601 Wyoming Avenue, Kingston, PA, 18704 | |
| (888) 923-5842 |
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| Name | Celtic Hospice |
|---|---|
| Location | 601 Wyoming Avenue, Kingston, Pennsylvania |
| Hospice ID | 391572 |
| Category | Part of a Home Health Agency |
| Ownership Type | Proprietary - Individual |
| Profit Type | FOR PROFIT |
| SSA county code | 480 |
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| NPI Number | 1164567186 |
| Organization Name | Celtic Hospice & Palliative Care Services Of Carlisle, Inc. |
| Address | 900 Century Dr Mechanicsburg, Pennsylvania, 17055 |
| Phone Number | (888)923-5842 |
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| NPI Number | 1235184904 |
| Organization Name | Hospice Community Care Inc |
| Address | 601 Wyoming Ave Kingston, Pennsylvania, 18704 |
| Phone Number | (570)288-2288 |
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| NPI Number | 1487955290 |
| Organization Name | Celtic Healthcare Of Ne Pa, Inc. |
| Address | 601 Wyoming Ave Kingston, Pennsylvania, 18704 |
| Phone Number | (888)923-5842 |
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.3 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 85.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 66.1 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.5 | 97.3 |
| Patients who got timely treatment for shortness of breath | 97.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.7 | 93.3 |
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| Home Health Aides | 17.6 |
| Counselors | 3.2 |
| Homemakers | 0.2 |
| Licensed Practical or Vocational Nurses | 3.8 |
| Medical Social Workers | 3.85 |
| Registered Nurses | 18.35 |
| Other Personnel | 4.2 |
| Total Employees | 51.2 |
|---|
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| Others | 0.9 |
| Total Volunteers | 0.9 |
|---|
News Archive
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
› Verified 9 days ago
| Celtic Hospice Location: 601 Wyoming Avenue, Kingston, Pennsylvania, 18704 Phone: (888) 923-5842 |
| Erwine's Home Health And Hospice Location: 270 Pierce Street Suite 101, Kingston, Pennsylvania, 18704 Phone: (888) 923-5842 |